Please login to the form below

Not currently logged in
Email:
Password:

Pfizer in talks to sell Kent, UK research facility

Pharma firm confirms advanced discussions with property consortium for sale of Discovery Park

Pfizer is in advanced discussions with a property consortium to sell its UK research facility in Sandwich, Kent.

The company said in February 2011 that it would close the plant, where erectile dysfunction drug Viagra was developed, leading to the loss of 2,400 jobs.

It was later announced that the number of layoffs would be reduced, with 650 workers to be retained at the site, and 250 transferred to other Pfizer R&D sites.

A Pfizer spokesperson said: “Following a structured selection process, Pfizer has entered into a period of legal exclusivity with a consortium led by London & Metropolitan and financed by a major European institutional real estate investor, for the sale of the Discovery Park campus in Sandwich, Kent.

“This announcement is a positive milestone in the transition of Discovery Park to becoming an R&D led multiple-use campus with Enterprise Zone status.”

Conservative MP for Thanet South, Laura Sandys, welcomed the news.

Speaking to the BBC, she said: "It means we'll be able to market the Discovery Park very effectively and ensure that we've got a vision for the Enterprise Zone that will attract new jobs and new companies."

Sandys also said London and Metropolitan had a “very clear vision about having a strong life-science park that will attract people internationally" following discussions with the potential buyers.

Pfizer intends to keep using a number of the Discovery Park facilities on a leased basis, but is looking for a buyer to take over the majority of the site, which occupies around 70 hectares and provides about 280,000 sq m of accommodation, including specialist laboratories.

Several ex-Pfizer employees at the site have gone on to set up their own research ventures.

In September, 2011, seven former Pfizer staff members helped set up The Research Network, which CEO Andrew McElroy described as a firm would help biotech and pharmaceutical companies find the right partners for outsourcing research productivity.

Separately, former Pfizer researchers have launched new companies based at BioCity Nottingham, one of Europe's largest bioscience business centres.

31st January 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Founded in 2011, Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective,...

Latest intelligence

The Heart of the Matter 9: Context is King
McCann Complete Medical outlines why multichannel communications - anchored in strong clinical data from journal publications - must not only be transparent, they must also provide a clear clinical context...
Cell and gene therapies: on course for commercial success?
...
eyeforpharma_h_logo.png
Make Anthill your strategic partner in Barcelona
We are excited to attend and exhibit at eyeforpharma Barcelona 2017 (March 14-16th), and present two multichannel strategy workshops....

Infographics